PRESS RELEASE published on 12/12/2024 at 21:30, 4 months 19 days ago Informations privilégiées / Autres communiqués Medincell intègre l'indice Euronext SBF 120 et CAC Mid 60, renforçant sa visibilité et attractivité pour les investisseurs. Découvrez les déclarations et impacts de cette intégration Euronext Intégration SBF 120 Medincell CAC Mid 60
PRESS RELEASE published on 12/10/2024 at 17:47, 4 months 21 days ago Medincell Rapport Financier semestriel 01-04-24 au 30-09-2024
BRIEF published on 11/28/2024 at 18:45, 5 months 2 days ago Medincell Announces Video Conference for Half-Year Results Half-year Results Schizophrenia Medincell Videoconference BEPO Technology
BRIEF published on 11/28/2024 at 18:45, 5 months 2 days ago Medincell annonce une vidéoconférence pour ses résultats semestriels Résultats Semestriels Schizophrénie Medincell Videoconference Technologie BEPO
PRESS RELEASE published on 11/28/2024 at 18:40, 5 months 2 days ago Informations privilégiées / Autres communiqués Medincell tiendra une vidéoconférence pour présenter ses résultats financiers semestriels le mardi 10 décembre 2024. La société développe des médicaments injectables à action prolongée dans divers domaines thérapeutiques Résultats Financiers Medincell Médicaments Injectables Videoconference Technologie BEPO
BRIEF published on 11/22/2024 at 18:05, 5 months 8 days ago MedinCell: Update of share capital and voting rights Share Capital Voting Rights Euronext Actions Medincell
BRIEF published on 11/22/2024 at 18:05, 5 months 8 days ago MedinCell : Mise à jour du capital social et des droits de vote Droits De Vote Euronext Capital Social Actions Medincell
PRESS RELEASE published on 11/22/2024 at 18:00, 5 months 8 days ago Informations privilégiées / Autres communiqués Euronext informe sur les droits de vote et le capital social de MedinCell. MedinCell, biopharmaceutique en France, développe des médicaments injectables à action prolongée Droits De Vote Euronext Capital Social Biopharmaceutique Medincell
BRIEF published on 11/06/2024 at 13:47, 5 months 24 days ago Medincell : Revenus 2024 à la hausse et avancée clinique significative Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
BRIEF published on 11/06/2024 at 13:47, 5 months 24 days ago Medincell: 2024 revenues on the rise and significant clinical progress Clinical Trial Revenue Projections Medincell Olanzapine LAI UZEDY
Published on 05/01/2025 at 02:00, 23 minutes ago EQ Inc. Reports Profitable Fourth Quarter and 2024 Year End Financial Results
Published on 05/01/2025 at 00:00, 2 hours 23 minutes ago Tecogen Announces Uplist to NYSE American Stock Exchange
Published on 04/30/2025 at 23:30, 2 hours 53 minutes ago Arras Minerals Announces Voting Results of Annual and Special Meeting of Shareholders
Published on 04/30/2025 at 23:20, 3 hours 3 minutes ago Justera Health Announces Director Resignation and Change to Fiscal Year End
Published on 04/30/2025 at 23:15, 3 hours 8 minutes ago Interactive Strength Inc. (Nasdaq:TRNR) Provides Shareholder Update on 2025 Developments
Published on 04/30/2025 at 23:30, 2 hours 52 minutes ago EEII AG: Ad-Hoc announcement pursuant to Art. 53 Listing Rules: EEII AG 2024 Annual Results
Published on 04/30/2025 at 22:43, 3 hours 39 minutes ago Assemblée générale ordinaire d’Espace Real Estate Holding AG
Published on 04/30/2025 at 21:15, 5 hours 8 minutes ago voxeljet AG announces financial restructuring with StaRUG procedure after general meeting rejects approval of the sale of the business to Anzu
Published on 04/30/2025 at 21:00, 5 hours 22 minutes ago Northern Data Group issues Business and Operational Update
Published on 04/30/2025 at 20:40, 5 hours 42 minutes ago EQS-Adhoc: Northern Data Group Updates 2025 Guidance and Provides New Guidance Framework
Published on 04/30/2025 at 19:14, 7 hours 8 minutes ago Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 7 hours 8 minutes ago Solocal - Communiqué de presse - Mise à disposition du DEU 2024
Published on 04/30/2025 at 18:55, 7 hours 27 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 5, 2025
